157 related articles for article (PubMed ID: 6315426)
1. Pharmacokinetic and microbial susceptibility studies of ceftriaxone.
Baumgartner JD; Glauser MP
Eur J Clin Microbiol; 1983 Oct; 2(5):501-4. PubMed ID: 6315426
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of ceftazidime and ceftriaxone.
Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
[TBL] [Abstract][Full Text] [Related]
3. The in vitro antibacterial activity of ceftriaxone in comparison with nine other antibiotics.
Emmerson AM; Lamport PA; Reeves DS; Bywater MJ; Holt HA; Wise R; Andrews J; Hall MJ
Curr Med Res Opin; 1985; 9(7):480-93. PubMed ID: 3928265
[TBL] [Abstract][Full Text] [Related]
4. Ceftriaxone: in vitro activity against 410 bacterial isolates compared with cefotaxime.
Digranes A; Benonisen E; Dibb WL
Infection; 1982; 10(5):307-9. PubMed ID: 6293978
[TBL] [Abstract][Full Text] [Related]
5. Ceftriaxone: a summary of in vitro antibacterial qualities including recommendations for susceptibility tests with 30-micrograms disks.
Jones RN; Barry AL; Thornsberry C
Diagn Microbiol Infect Dis; 1983 Dec; 1(4):295-311. PubMed ID: 6321093
[TBL] [Abstract][Full Text] [Related]
6. [Patterns of resistance of Staph aureus and gram-negative bacteria to aminoglycosides and cephalosporins].
Ruczkowska J; Dolna I
Wiad Lek; 1989 May; 42(9):579-83. PubMed ID: 2629327
[TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro activity of ceftriaxone against clinical bacterial isolates in Nigeria.
Obaseiki-Ebor EE; Afonya TC; Oyaide SM
Chemotherapy; 1985; 31(2):130-7. PubMed ID: 3872779
[TBL] [Abstract][Full Text] [Related]
8. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
[TBL] [Abstract][Full Text] [Related]
9. The in-vitro activity of ceftazidime compared with that of other cephalosporins.
Bint AJ; Yeoman P; Kilburn P; Anderson R; Stansfield E
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():47-51. PubMed ID: 19802968
[TBL] [Abstract][Full Text] [Related]
10. An in-vitro comparison of new cephalosporins with special reference to Pseudomonas aeruginosa.
van Klingeren B
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():97-105. PubMed ID: 19810171
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity in vitro and regression studies for ceftazidime and ceftriaxone.
Frimodt-Møller N; Højbjerg T; Hvass E; Møller S; Mortensen I; Thomsen VF
Acta Pathol Microbiol Immunol Scand B; 1985 Jun; 93(3):181-8. PubMed ID: 3929558
[TBL] [Abstract][Full Text] [Related]
12. Comparative in-vitro activity and mode of action of ceftriaxone (Ro 13-9904), a new highly potent cephalosporin.
Hall MJ; Westmacott D; Wong-Kai-In P
J Antimicrob Chemother; 1981 Sep; 8(3):193-203. PubMed ID: 6270051
[No Abstract] [Full Text] [Related]
13. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
[TBL] [Abstract][Full Text] [Related]
14. Ceftriaxone - a new broad-spectrum semisynthetic cephalosporin. In vitro activity against gram-negative bacilli sensitive and resistant to gentamicin.
Bremner DA
Chemotherapy; 1983; 29(4):283-8. PubMed ID: 6307605
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin.
Neu HC; Meropol NJ; Fu KP
Antimicrob Agents Chemother; 1981 Mar; 19(3):414-23. PubMed ID: 6972729
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of Ro 13-9904.
Hinkle AM; Bodey GP
Antimicrob Agents Chemother; 1980 Oct; 18(4):574-8. PubMed ID: 6778383
[TBL] [Abstract][Full Text] [Related]
17. [Activity of fourth generation cephalosporins against clinical isolates of Enterobacteriaceae].
Tuchiluş C; Poiată A; Bădicuţ I; Teodor A; Luca V; Grigore L; Buiuc D
Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):595-8. PubMed ID: 14756068
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of Ro 13-9904, a new beta-lactamase-stable cephalosporin.
Verbist L; Verhaegen J
Antimicrob Agents Chemother; 1981 Feb; 19(2):222-5. PubMed ID: 6289726
[TBL] [Abstract][Full Text] [Related]
19. Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
Norris SM; Guenthner SH; Wenzel RP
J Antimicrob Chemother; 1985 Aug; 16(2):183-8. PubMed ID: 3934124
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of respiratory isolates of Enterobacteriaceae and Staphylococcus aureus in Italy: incidence and trends over the period 1997-1999.
Fontana R; Lo Cascio G; Ligozzi M; Friscia O; Oldoni T;
Eur J Clin Microbiol Infect Dis; 2001 Dec; 20(12):854-63. PubMed ID: 11837636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
